PFS Partners’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
FFM
SP
PFS Partners's AMGN Position: Q2 2026 in Review
PFS Partners increased its Amgen (AMGN) stake by 2.3% in Q2 2026, buying an estimated $342 and bringing the position to 44 shares worth $15.8K. The position accounts for 0.01% of the portfolio, ranked #329.
PFS Partners first reported a position in AMGN in Q4 2025 and has held it in 3 quarters since. The position peaked at $20.4K in Q4 2025. 1,241 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.
- PFS Partners held 44 shares of Amgen worth $15.8K as of Q2 2026.
- PFS Partners bought 1 Amgen share in Q2 2026, an estimated $342.
- Amgen made up 0.01% of PFS Partners's portfolio in Q2 2026, its #329 holding.
- PFS Partners first reported a position in Amgen in Q4 2025 and has held it in 3 quarters since.
- PFS Partners's Amgen position peaked at $20.4K in Q4 2025.
- 1,241 funds tracked by Wall St. Rank held Amgen as of Q2 2026.
Based on PFS Partners's 13F filing for Q2 2026, filed 20 Jul 2026.